Navigation Links
STAAR Surgical Reports Strong Second Quarter Financial Results
Date:7/31/2013

cash, including reinvested interest-129Net cash used in investing activities(2,017)(704)Cash flows from financing activities:Repayment of capital lease lines of credit(478)(438)Proceeds from exercise of stock options952950Net cash provided by financing activities474512Effect of exchange rate changes on cash and cash equivalents(763)(74)Increase (decrease) in cash and cash equivalents(1,950)962Cash and cash equivalents, at beginning of the period21,67516,582Cash and cash equivalents, at end of the period$19,725$17,544 STAAR Surgical CompanyGlobal Sales(in 000's)UnauditedThree Months EndedYear EndedJune 28,June 29,% ChangeJune 28,June 29,% ChangeGeographic Sales20132012Fav (Unfav)20132012Fav (Unfav)United States

17.4%

$   3,154

20.2%

$   3,216-1.9%17.7%

$   6,394

20.3%

$   6,3900.1%Japan

25.6%

4,648

25.7%

4,09413.5%25.9%

9,387

25.3%

7,95118.1%Korea

10.1%

1,834

10.8%

1,7216.6%10.7%

3,869

11.5%

3,6246.8%China

12.3%

2,230

13.4%

2,1414.2%11.9%

4,301

13.5%

4,2471.3%Spain

6.4%

1,163

3.3%

531119.0%6.8%

2,454

3.3%

1,041135.7%Other

28.2%

5,135

26.6%

4,23921.1%27.0%

9,760

26.1%

8,19819.1%  Total International Sales

82.6%

15,010

79.8%

12,72617.9%82.3%

29,771

79.7%

25,06118.8%Total Sales

100.0%

$  18,164

100.0%

$  15,94213.9%100.0%

$  36,165

100.0%

$  31,45115.0%Product Sales  Core productsICLs

62.0%

$  11,261

54.0%

$   8,60630.9%60.5%

$  21,892

54.7%


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
2. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
3. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
4. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
5. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
6. STAAR Surgical Reports Second Quarter 2012 Financial Results
7. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
8. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
9. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
10. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
11. STAAR Surgical Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... WINNIPEG , March 27, 2015 /PRNewswire/ - Medicure ... Board of Directors has approved the grant of an ... management company employees and consultants of the Company pursuant ... 181,070 are set to expire on the tenth anniversary ... expire on the third anniversary of the date of ...
(Date:3/27/2015)... 27, 2015 /CNW Telbec/ - Russell Williams , ... Companies (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the ... on the biopharmaceutical industry. However, the association is concerned ... "We commend the government,s intent to strive for a ... to promote Quebec,s economic development ...
(Date:3/27/2015)... 27, 2015 Biopharmaceutical Industry Leads Manufacturing ... comes out on top as the country,s manufacturing leader ... report  from ndp│analytics. According to the  analysis , the ... over the last decade, accounting for 27 percent of ... A Short Video on Medicare Part D ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians ... osteoarthritis and musculoskeletal diseases gathered here for the ... first time in the 17-year history of the ... topic is an emerging non-pharmaceutical protocol for enhancing ... of Wolff’s law, osteogenic loading at multiples of ...
(Date:3/28/2015)... An article in Fortune on Monday, March ... to organizations that deal with PCI (Payment Card Information); ... security, is worsening . Using numbers from Verizon’s ... category out of the twelve measured improved, barring one ... craziness that has gone on in the retail industry ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... WASHINGTON , April 18 The Federal Court ... unanimous 3-judge decision,today issued an opinion supporting the ... holding that it is entitled to renew its,constitutional ... Columbia,s AccessRx Act of 2004., Last year, ...
... April 18 Breckenridge Pharmaceutical,Inc. announced today that ... approval for the Company,s Abbreviated New Drug Application ... Activella Tablets,(Estradiol/Norethindrone Acetate 1.0mg / 0.5mg) Tablets., ... a,brand product marketed by Novo Nordisk(R), which is ...
... result of age, body composition , , FRIDAY, April 18 ... younger age or body composition may not explain why ... of creatinine than white patients, says a U.S. study ... is a standard indicator of kidney function. A higher ...
... 18 Sales leaders and,organizations that regularly ... art of motivating their sales representatives. Organizations ... personnel can use the key findings,discovered in ... &,Recognizing Top-Performing Sales People.",( http://www3.best-in-class.com/dr295.htm ), ...
... ARBOR, Mich. Right now, about half of all people ... help from it. And doctors have no definitive way to ... prescription they write. , But a University of Michigan ... more certainty to how doctors and patients choose anxiety treatments, ...
... as much as drug treatments , , FRIDAY, April 18 ... symptoms in patients with terminal cancer, according to Japanese ... included a total of 517 patients with incurable cancer ... treatment for these patients was supportive expressive group therapy, ...
Cached Medicine News:Health News:PCMA: Court of Appeals Upholds Challenge to D.C.'s PBM Fiduciary-Disclosure Law 2Health News:Muscle Mass May Not Explain High Creatinine in Black Kidney Patients 2Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2Health News:High anxiety? 2Health News:High anxiety? 3Health News:High anxiety? 4Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein...
... Angiotensin Converting Enzyme (ACE) is an integral ... the generation of Angiotensin II as well ... many different cell types, ACE is primarily ... only an important diagnostic parameter for sarcoidosis ...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
... evaluation of pancreatic -cell function is not only ... of the natural history of diabetes mellitus, but ... guide to the correct choice of treatment. Peripheral ... function because of the large and variable uptake ...
Medicine Products: